Available in 12
locations and 7
The Privacy Shield: how will it impact on the pharmaceutical sector?
Life Sciences & Healthcare Update & Alert
The Patents Court has granted Actavis a declaration in relation to its new pemetrexed product in its dispute with Eli Lilly.
The Supreme Court has set out a new test for the assessment of whether a provision in an agreement should be struck down as a penalty clause
The Patents Court has granted an interim injunction in respect of dealings in full label generic pregabalin products.
The Patents Court has decided that a patent relating to capsules used in a dry powder inhaler is invalid.
The Patents Court has rejected a validity attack against a patent relating to immunotherapy treatment for cancer.
The Commission confirms it is considering introduction of a Unitary SPC and consider recalibration of the SPC regime.
HMRC issues consultation on revisions to the Patent Box regime.
The Patents Court has refused to stay infringement proceedings relating to e-cigarettes pending an opposition before the EPO.
The Patents Court has granted an interim injunction to Teva in a patent infringement action.
Court of Justice clarified relevant date of first authorisation for purposes of calculating length of SPC.
The Patents Court has found Pfizer’s second medical use patent relating to pregabalin invalid on the grounds of insufficiency.
The Court of Appeal has overturned Birss J’s finding of invalidity in relation to psoriasis ointment patents.